3M MMM has been analyzed by 10 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 3 | 3 | 2 | 2 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 2 | 2 | 1 | 1 | 0 |
2M Ago | 0 | 1 | 1 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 1 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $152.5, a high estimate of $184.00, and a low estimate of $100.00. This upward trend is evident, with the current average reflecting a 13.81% increase from the previous average price target of $134.00.
Breaking Down Analyst Ratings: A Detailed Examination
The standing of 3M among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Damian Karas | UBS | Raises | Buy | $184.00 | $130.00 |
Stephen Tusa | JP Morgan | Raises | Overweight | $165.00 | $160.00 |
Deane Dray | RBC Capital | Raises | Underperform | $100.00 | $99.00 |
Andrew Obin | B of A Securities | Raises | Buy | $160.00 | $143.00 |
Julian Mitchell | Barclays | Raises | Overweight | $165.00 | $160.00 |
Scott Davis | Melius Research | Announces | Buy | $180.00 | - |
Brett Linzey | Mizuho | Raises | Neutral | $146.00 | $105.00 |
Joe O'Dea | Wells Fargo | Raises | Equal-Weight | $140.00 | $130.00 |
Julian Mitchell | Barclays | Raises | Overweight | $160.00 | $145.00 |
Chris Snyder | Morgan Stanley | Announces | Underweight | $125.00 | - |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to 3M. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of 3M compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of 3M's stock. This comparison reveals trends in analysts' expectations over time.
Capture valuable insights into 3M's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on 3M analyst ratings.
Unveiling the Story Behind 3M
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
3M: Delving into Financials
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: 3M displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 0.38%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: 3M's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 21.8%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 32.06%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): 3M's ROA excels beyond industry benchmarks, reaching 3.26%. This signifies efficient management of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 2.97, 3M faces challenges in effectively managing its debt levels, indicating potential financial strain.
What Are Analyst Ratings?
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.